Related Articles
Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells
The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells
Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic Bcl-2
Epigenetic regulation of hTERT promoter in hepatocellular carcinomas
Pristimerin inhibits the proliferation of HT1080 fibrosarcoma cells by inducing apoptosis